Kenvue

Kenvue Financial Leverage

The Financial Leverage (Equity Multiplier) of Kenvue (KVUE) as of Nov 3, 2026 is 2.52. In the previous year, Financial Leverage (Equity Multiplier) was 2.65 — a change of -5.02% (lower).

Financial Leverage

2.52

YoY

-5.02%

Last updated:

Financial Leverage (Equity Multiplier) of Kenvue is 2025 2.52 . Financial Leverage (Equity Multiplier) of Kenvue was 2024 2.65 . It decreases by -5.02% lower compared to the previous year.

The Kenvue Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2020
1.59 USD
Jan 1, 2021
1.37 USD
Jan 1, 2022
1.37 USD
Jan 1, 2023
2.48 USD
Jan 1, 2024
2.65 USD
Jan 1, 2025
2.52 USD
The Kenvue Financial Leverage history
YEARFinancial LeverageYoY
2.52-5.02%
2.65+6.59%
2.48+81.62%
1.37-0.09%
1.37-13.86%
1.59—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kenvue Stock analysis

What does Kenvue do? Kenvue Inc. generates revenue through its three business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment sells products like Tylenol for pain care, Zyrtec for allergies, and Nicorette for smoking cessation. The Skin Health and Beauty segment offers Neutrogena face and body care, Listerine for oral hygiene, and Aveeno for skin health. Essential Health includes Johnson’s baby care, Band-Aid for wound care, and oral care products. These brands target consumers globally across 165 countries, with distribution via 114 centers and 38 customer service hubs. Kenvue’s differentiated brand portfolio drives sales, with Tylenol, Neutrogena, and Listerine as key products. The Self Care segment focuses on cough, cold, and allergy remedies, while Skin Health and Beauty emphasizes face and body care. Essential Health covers oral care, baby care, and women’s health products. The company serves consumers directly through retail channels in all regions, leveraging its global distribution network. The company’s revenue streams come from selling its branded products in self-care, skin health, and essential health categories. Tylenol leads in pain care, Neutrogena dominates face and body care, and Johnson’s is prominent in baby care. Brands like Listerine and Aveeno cater to oral and skin health needs, while Band-Aid addresses wound care. Sales occur across 165 countries through 114 distribution centers and 38 customer service centers. Kenvue is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kenvue stock

Financial Leverage (Equity Multiplier) of Kenvue is 2.52 in 2025.

Financial Leverage (Equity Multiplier) of Kenvue changed from 2.65 to 2.52, representing a -5.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Kenvue since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Kenvue with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Kenvue

All Key Metrics — Kenvue